Regulus Announces Pipeline Updates and Advancements

Phase II RG-012 HERA and Renal Biopsy studies for Alport syndrome move forward Discontinuing clinical development of RG-101 Pre-clinical pipeline progresses LA JOLLA, Calif., June 12, 2017 -- (Healthcare Sales & Marketing Network) -- Regulus Ther... Biopharmaceuticals Regulus Therapeutics, microRNAs
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news